Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Reviews on Recent Clinical Trials|June 3, 2022
Alcoholic Consumption of Young Italians During the SARS-CoV-2 PandemicAlessandro Federico, Chiara Mazzarella, Annamaria Spina, et al.Oxidative Medicine and Cellular Longevity|November 19, 2019
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease PatientsAlessandro Federico, Marcello Dallio, Mario Masarone, et al.Internal and Emergency Medicine|October 2, 2017
Lactate determination in pleural and abdominal effusions: a quick diagnostic marker of exudate-a pilot studyGiovanni Porta, Fabio G Numis, Valerio Rosato, et al.Antiviral Therapy|August 12, 2017
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosisMarcello Persico, Valerio Rosato, Andrea Aglitti, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 1, 2023
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre studyNicola Pugliese, Vincenza Calvaruso, Mario Masarone, et al.Cardiovascular Diabetology|June 3, 2026
Cardiac remodeling after bariatric surgery associates with systemic metabolic reprogramming: a longitudinal untargeted metabolomics studyIzzo Carmine, Lombardi Martina, Rusciano Maria Rosaria, et al.International Journal of Environmental Research and Public Health|August 31, 2019
Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver DiseaseMarcello Dallio, Nadia Diano, Mario Masarone, et al.Life (Basel, Switzerland)|December 23, 2020
Screening, Linkage to Care and Treatment of Hepatitis C Infection in Primary Care Setting in the South of ItalyAnna Citarella, Simona Cammarota, Francesca F Bernardi, et al.Reviews on Recent Clinical Trials|December 18, 2015
Impact of Telaprevir in HCV Patients with Cirrhosis and RVR: Real-Life Data from Boceprevir or Telaprevir based "Triple Therapy" Experience in Southern ItalyFilomena Morisco, Mario Masarone, Valerio Rosato, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 16, 2025
ITA-MASLD: A national observational study to characterize the profile of patients with MASLD in specialistic care in ItalyElisabetta Bugianesi, Silvio Buscemi, Patrizia Burra, et al.Pageof 8